miRNAs; a novel strategy for the treatment of COVID‐19-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

miRNAs; a novel strategy for the treatment of COVID‐19

Published:2021-07-05 Issue:10 Volume:45 Page:2045-2053
ISSN:1065-6995
Container-title:Cell Biology International
language:en
Short-container-title:Cell Biol Int

Author:

Ying Hao¹,Ebrahimi Mohsen²,Keivan Mona³,Khoshnam Seyed Esmaeil⁴,Salahi Sarvenaz⁵,Farzaneh Maryam³^ORCID

Affiliation:

1. Zhuji People's Hospital of Zhejiang Province Zhuji Affiliated Hospital of Shaoxing University Zhuji China

2. Neonatal and Children's Health Research Center Golestan University of Medical Sciences Gorgan Iran

3. Fertility, Infertility and Perinatology Research Center Ahvaz Jundishapur University of Medical Sciences Ahvaz Iran

4. Persian Gulf Physiology Research Center, Medical Basic Sciences Research Institute Ahvaz Jundishapur University of Medical Sciences Ahvaz Iran

5. Minimally Invasive Surgery Research Center Iran University of Medical Sciences Tehran Iran

Publisher

Wiley

Subject

Cell Biology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cbin.11653

Reference100 articles.

1. Coronavirus disease 2019 (COVID-19) outbreak in Iran: Actions and problems

2. Micro-RNAs in the regulation of immune response against SARS CoV-2 and other viral infections

3. miRCOVID-19: Potential Targets of Human miRNAs in SARS-CoV-2 for RNA-Based Drug Discovery

4. The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities

5. MicroRNA Involvement in Signaling Pathways During Viral Infection

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-source data integration for explainable miRNA-driven drug discovery;Future Generation Computer Systems;2024-11

2. Exploration of microRNAs as transcriptional regulator in mumps virus infection through computational studies;Scientific Reports;2024-08-14

3. Effectiveness of dolutegravir in moderate severity COVID-19 patients: A single-center, randomized, double-blind, placebo-controlled trial;BioImpacts;2024-06-26

4. miR-486-5p predicted adverse outcomes of SCAP and regulated K. pneumonia infection via FOXO1;BMC Immunology;2024-06-04

5. Regulatory role of miRNAs in the human immune and inflammatory response during the infection of SARS‐CoV‐2 and other respiratory viruses: A comprehensive review;Reviews in Medical Virology;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3